Collaborate with the EXAKT (Examination of Xylazine Associated Skin and Soft Tissue Infection) and EXOUD (EXtended-release Opioid Use Disorder treatment in Massachusetts) teams in Dr. Stopka's lab, as well as other agencies, to help coordinate and carry out: recruitment, consent processes, enrollment, data collection, data management, quality improvement, and data analysis related to qualitative and quantitative (e.g., survey) study activities in communities across Massachusetts. Finally, through our Mental Health and Opioid Prevention Explorer (mHOPE), an online, interactive data dashboard, we are helping to highlight the geospatial distribution of mental illness and opioid-related outcomes across US counties, as well as access to treatment services.